OCULAR THERAPEUTIX INC's ticker is OCUL and the CUSIP is 67576A100. A total of 72 filers reported holding OCULAR THERAPEUTIX INC in Q4 2015. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $402,000 | -13.2% | 65,000 | +30.0% | 0.01% | -15.4% |
| Q2 2017 | $463,000 | -28.8% | 50,000 | -28.6% | 0.01% | -23.5% |
| Q1 2017 | $650,000 | +10.9% | 70,000 | 0.0% | 0.02% | +6.2% |
| Q4 2016 | $586,000 | +21.8% | 70,000 | 0.0% | 0.02% | +6.7% |
| Q3 2016 | $481,000 | +39.0% | 70,000 | 0.0% | 0.02% | +36.4% |
| Q2 2016 | $346,000 | -20.5% | 70,000 | +55.6% | 0.01% | -21.4% |
| Q1 2016 | $435,000 | +3.1% | 45,000 | 0.0% | 0.01% | +27.3% |
| Q4 2015 | $422,000 | +11.1% | 45,000 | +66.7% | 0.01% | +22.2% |
| Q3 2015 | $380,000 | – | 27,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SV Health Investors, LLC | 1,932,607 | $40,643,000 | 15.56% |
| Lamond Capital Partners LLC | 711,533 | $14,964,000 | 15.19% |
| Polaris Venture Management Co. V, L.L.C. | 1,230,009 | $25,867,000 | 11.54% |
| NOTTINGHAM ADVISORS, INC. | 171,985 | $3,617,000 | 0.60% |
| Portolan Capital Management | 122,518 | $2,577,000 | 0.36% |
| SPHERA FUNDS MANAGEMENT LTD. | 160,000 | $3,365,000 | 0.33% |
| Rotella Capital Management, Inc. | 18,461 | $388,000 | 0.32% |
| Monashee Investment Management LLC | 28,834 | $606,000 | 0.29% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 335,498 | $7,056,000 | 0.24% |
| BAILARD, INC. | 55,000 | $1,157,000 | 0.18% |